| Symbol | APTOF |
|---|---|
| Name | APTOSE BIOSCIENCES. INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | M5K 1E6 Canada ON 66 Wellington Street West Suite 5300 |
| Telephone | (647) 479-9828 |
| Fax | — |
| — | |
| Website | https://www.aptose.com/ |
| Incorporation | CA |
| Incorporated On | 1984 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | KPMG LLP.; |
| Audit Status | AUDITED |
| Reporting Status | U.S. Reporting: SEC Reporting |
| CIK | 0000882361 |
| Description | Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. Additional info from OTC: |
No news found.